Drug application
MELPHALAN HYDROCHLORIDE (MELPHALAN HYDROCHLORIDE)
Drugs@FDA ANDA 204817 · ALMAJECT
Key facts
| Drug name | MELPHALAN HYDROCHLORIDE |
|---|---|
| Active ingredients | MELPHALAN HYDROCHLORIDE |
| Application type | ANDA |
| Application number | 204817 |
| Company | ALMAJECT |
| Dosage forms | INJECTABLE, INJECTION |
| Strength | EQ 50MG BASE/VIAL |
| Marketing status | Discontinued |
| TE codes | AP |
| Reference listed drug | No |
| Latest submission status date | May 17, 2019 |
At a glance
- 1–9 Submissions
- None Label versions
- 1–9 Products
- 10–99 Therapeutic equivalents
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.